Literature DB >> 16823693

Immunohistochemical expression of progesterone and estrogen receptors in meningiomas.

Aleksandra Omulecka1, Wielisław Papierz, Agnieszka Nawrocka-Kunecka, Iwona Lewy-Trenda.   

Abstract

In this study we present results of investigations of progesterone and estrogen receptors in most frequent, WHO grade I histological types of meningiomas (meningothelial, fibrous, and transitional) and in atypical--WHO grade II variant of these tumors. Samples from 64 tumors were examined. The cohort consisted of 46 WHO grade I (21 transitional, 13 fibrous and 12 meningothelial histologic variants) and of 18 atypical meningiomas. Apart from immunohistochemical examination of progesterone and estrogen receptors, MIB 1 labeling index was estimated. Positive immunoreaction for progesterone receptors was found in 100% meningothelial, 95% transitional, 46% fibrous and 78% atypical variant of meningiomas. Intensity of immunoreaction was stronger in grade I than in grade II tumors. Immunoexpression of estrogen receptors was found in 48% of the investigated meningiomas. No correlation was stated between WHO grade I and grade II tumors, and between meningothelial, transitional and fibrous variants of the neoplasms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823693

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  10 in total

1.  Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines.

Authors:  Olivia Tania Hernández-Hernández; Mauricio Rodríguez-Dorantes; Aliesha González-Arenas; Ignacio Camacho-Arroyo
Journal:  Endocrine       Date:  2009-12-05       Impact factor: 3.633

Review 2.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

3.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

Review 4.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

5.  Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma.

Authors:  Avninder Singh; Ashwani Kumar Mishra; Kris Ylaya; Stephen M Hewitt; Karam Chand Sharma; Sunita Saxena
Journal:  Pathol Oncol Res       Date:  2011-09-10       Impact factor: 3.201

6.  Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series.

Authors:  Antoine Devalckeneer; Rabih Aboukais; Maxime Faisant; Philippe Bourgeois; Vannod-Michel Quentin; Claude-Alain Maurage; Fabienne Escande; Jean-Paul Lejeune
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

Review 7.  Current therapeutic options for breast cancer central nervous system metastases.

Authors:  M Brian Hemphill; Julia A Lawrence
Journal:  Curr Treat Options Oncol       Date:  2008-04-05

8.  Risk of intracranial meningioma with three potent progestogens: A population-based case-control study.

Authors:  Léa Hoisnard; Moussa Laanani; Thibault Passeri; Lise Duranteau; Joël Coste; Mahmoud Zureik; Sébastien Froelich; Alain Weill
Journal:  Eur J Neurol       Date:  2022-06-20       Impact factor: 6.288

9.  Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis.

Authors:  Theodoros N Sergentanis; Georgios Tsivgoulis; Christina Perlepe; Ioannis Ntanasis-Stathopoulos; Ioannis-Georgios Tzanninis; Ioannis N Sergentanis; Theodora Psaltopoulou
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

10.  Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications.

Authors:  Francesco Maiuri; Giuseppe Mariniello; Oreste de Divitiis; Felice Esposito; Elia Guadagno; Giuseppe Teodonno; Marcello Barbato; Marialaura Del Basso De Caro
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.